[HTML][HTML] Bortezomib enhances cancer cell death by blocking the autophagic flux through stimulating ERK phosphorylation
C Kao, A Chao, CL Tsai, WC Chuang, WP Huang… - Cell death & …, 2014 - nature.com
The antitumor activity of an inhibitor of 26S proteasome bortezomib (Velcade) has been
observed in various malignancies, including colon cancer, prostate cancer, breast cancer …
observed in various malignancies, including colon cancer, prostate cancer, breast cancer …
Bortezomib enhances cancer cell death by blocking the autophagic flux through stimulating ERK phosphorylation
C Kao, A Chao, CL Tsai, WC Chuang… - Cell Death and …, 2014 - pure.lib.cgu.edu.tw
摘要The antitumor activity of an inhibitor of 26S proteasome bortezomib (Velcade) has been
observed in various malignancies, including colon cancer, prostate cancer, breast cancer …
observed in various malignancies, including colon cancer, prostate cancer, breast cancer …
[HTML][HTML] Bortezomib enhances cancer cell death by blocking the autophagic flux through stimulating ERK phosphorylation
C Kao, A Chao, CL Tsai, WC Chuang… - Cell Death & …, 2014 - ncbi.nlm.nih.gov
The antitumor activity of an inhibitor of 26S proteasome bortezomib (Velcade) has been
observed in various malignancies, including colon cancer, prostate cancer, breast cancer …
observed in various malignancies, including colon cancer, prostate cancer, breast cancer …
[PDF][PDF] Bortezomib enhances cancer cell death by blocking the autophagic flux through stimulating ERK phosphorylation
C Kao, A Chao, CL Tsai, WC Chuang… - Cell Death and …, 2014 - cyberleninka.org
Results Bortezomib specifically elicited autophagy but blocked the degradation of p62.
Treatment with bortezomib increased GFP-LC3 puncta (Figure 1a) and the formation of a …
Treatment with bortezomib increased GFP-LC3 puncta (Figure 1a) and the formation of a …
Bortezomib enhances cancer cell death by blocking the autophagic flux through stimulating ERK phosphorylation
C Kao, A Chao, C Tsai, W Chuang… - Cell Death and …, 2014 - search.proquest.com
The antitumor activity of an inhibitor of 26S proteasome bortezomib (Velcade) has been
observed in various malignancies, including colon cancer, prostate cancer, breast cancer …
observed in various malignancies, including colon cancer, prostate cancer, breast cancer …
[PDF][PDF] Bortezomib enhances cancer cell death by blocking the autophagic flux through stimulating ERK phosphorylation
C Kao, A Chao, CL Tsai, WC Chuang… - Cell Death and …, 2014 - researchgate.net
Results Bortezomib specifically elicited autophagy but blocked the degradation of p62.
Treatment with bortezomib increased GFP-LC3 puncta (Figure 1a) and the formation of a …
Treatment with bortezomib increased GFP-LC3 puncta (Figure 1a) and the formation of a …
Bortezomib enhances cancer cell death by blocking the autophagic flux through stimulating ERK phosphorylation
C Kao, A Chao, CL Tsai, WC Chuang, WP Huang… - Cell Death & …, 2014 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> The antitumor activity of an inhibitor of 26S
proteasome bortezomib (Velcade) has been observed in various malignancies, including …
proteasome bortezomib (Velcade) has been observed in various malignancies, including …
[引用][C] Bortezomib enhances cancer cell death by blocking the autophagic flux through stimulating ERK phosphorylation.
C Kao, A Chao, CL Tsai, WC Chuang… - Cell Death & Disease …, 2014 - ir.sinica.edu.tw
Issue Date: 2014-11 Relation: Cell Death & Disease 5 (11), e1510 URI: http://ir. sinica. edu.
tw/handle/201000000A/9356 ISSN: http://gateway. isiknowledge. com/gateway/Gateway …
tw/handle/201000000A/9356 ISSN: http://gateway. isiknowledge. com/gateway/Gateway …
Bortezomib enhances cancer cell death by blocking the autophagic flux through stimulating ERK phosphorylation.
C Kao, A Chao, CL Tsai, WC Chuang… - Cell Death & …, 2014 - europepmc.org
The antitumor activity of an inhibitor of 26S proteasome bortezomib (Velcade) has been
observed in various malignancies, including colon cancer, prostate cancer, breast cancer …
observed in various malignancies, including colon cancer, prostate cancer, breast cancer …
Bortezomib enhances cancer cell death by blocking the autophagic flux through stimulating ERK phosphorylation
C Kao, A Chao, CL Tsai, WC Chuang… - Cell death & …, 2014 - pubmed.ncbi.nlm.nih.gov
The antitumor activity of an inhibitor of 26S proteasome bortezomib (Velcade) has been
observed in various malignancies, including colon cancer, prostate cancer, breast cancer …
observed in various malignancies, including colon cancer, prostate cancer, breast cancer …